Why a Patient With Multiple Myeloma Might Decline Stem Cell Transplant: Mansi Shah, MD
Financial, family, and logistical challenges often lead patients to choose ongoing therapies over stem cell transplantation, says Mansi Shah, MD.
How Transplant, CAR T, and Bispecifics Fit Into Myeloma Care: Mansi Shah, MD
Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple myeloma.
Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD
Mansi Shah, MD, discusses the role of stem cell transplant in multiple myeloma (MM) and the logistical barriers to wider adoption of bispecific therapies.
